News
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announced the pricing of an underwritten public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback